Pre-madeoptionalinducIBLelentiviralparticlesforexpressinghumantarget:hLOXL2(alternativename:LOR2,WS9-14),withORFsequence100%matchingtoCDSregioninNCBIID:NM_002318.2.ParticlesalsocontainsaRFP-BlasticidindualselectionMarker.
Full sequenceverifiedtargetisnativelyexpressedunderatetracyclineinduciblesuCMVpromoter(Note:itcan alsousedasregularconstitutivehighexpression,seemanualfordetails).Ablasticidin-RFPfusionmarkerunderRSVpromoter,allowstosortorselecttransducedcellsforlongtermexpressionviaRFPsignalorviablasticidinantibiotic(Dualmarkers).RFPsignalprovidesaconvenient,realtimemonitoringtheparticlesperformance.Eachparticleswasvalidatedinlotbylotbasisandtargetexpressionisguaranteed.Particleswerepackagedinserum-freesolutioncontainingnoanyhumanoranimalorigincomponents.Seeproductmanualfordetails(.pdf).
Amount:200ul,at1x107IFU/mlinserum-freemedium.
Cat#:LVP422
